PatientPop Stock

patientpop.comHealthcare / Healthcare softwareFounded: 2014Funding to Date: $125.82MM

PatientPop is the provider of an all-in-one practice growth solution designed to enhance and automate each touchpoint in the patient journey — from first impression online to digital booking to post-visit follow-up — to makes it easy for healthcare providers to attract more patients, manage online reputation, modernize the patient experience, and automate the front office.

Register To Buy and Sell Private Company Shares

For more details on financing and valuation of private companies similar to PatientPop before its M&A, register or login today.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

PatientPop Stock Price

Forge Price 1
Price not available
Last Closed Trade 2
Close Date
xx/xx/xx
Last Closed Trade Price
$xx.xx
Last Funding Round (LFR)
Date
xx/xx/xx
Price per Share
$xx.xx

PatientPop Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
08/25/2020 Series C-1 $3.39MM $xx.xx $425.93MM Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
Price per Share
$xx.xx
Shares Outstanding
341,859
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
08/25/2020 Series C-3 $4.5MM $xx.xx $425.93MM Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
Price per Share
$xx.xx
Shares Outstanding
453,400
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
08/25/2020 Series C-2 $5.61MM $xx.xx $425.93MM Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
Price per Share
$xx.xx
Shares Outstanding
564,942
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
08/25/2020 Series C $42.65MM $xx.xx $425.93MM Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
Price per Share
$xx.xx
Shares Outstanding
4,297,717
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Commonfund, Hlm Venture Partners, Silicon Valley Bank, Toba Capital, Transformation Capital, Vivo Capital
10/22/2018 Series B-2 $5MM $xx.xx $385.8MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
548,846
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
10/22/2018 Series A-5 $10MM $xx.xx $385.8MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
1,321,003
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
10/22/2018 Series B-1 $15MM $xx.xx $385.8MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
1,646,542
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
10/22/2018 Series A-4 $15MM $xx.xx $385.8MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
2,920,390
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
12/29/2016 Series A-3 $4.5MM $xx.xx $148.3MM Undisclosed Investors
Price per Share
$xx.xx
Shares Outstanding
1,265,502
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
05/17/2016 Series A-2 $7.57MM $xx.xx $121.18MM Athenahealth, Silicon Valley Bank, Toba Capital
Price per Share
$xx.xx
Shares Outstanding
2,599,161
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Athenahealth, Silicon Valley Bank, Toba Capital
11/04/2015 Series A $10.03MM $xx.xx $91.72MM Toba Capital
Price per Share
$xx.xx
Shares Outstanding
4,520,473
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Toba Capital
05/13/2015 Series Seed $504,997.00 $xx.xx $29.69MM --
Price per Share
$xx.xx
Shares Outstanding
841,661
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
--
05/13/2015 Series Seed-2 $2.05MM $xx.xx $29.69MM Athenahealth
Price per Share
$xx.xx
Shares Outstanding
2,828,211
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Athenahealth

Leadership & Board

Leadership

Travis Schneider
Board Member, Co-Founder & Co-Chief Executive Officer
Nick Bellomo
Chief Financial Officer
Christophe Louvion
Chief Technology Officer
Luke Kervin
Board Member, Co-Founder & Co-Chief Executive Officer
Taylor Timmer
Co-Founder
Carla Nichols
Chief Customer Officer
Jonathan Wetzel
Executive

Board

Luke Kervin
PatientPop
Patrick Mathieson
Toba Capital
Travis Schneider
PatientPop
Jonathan Bush
Steven Tolle
HLM Venture Partners
Nathan Dau JD
Vivo Capital
Todd Cozzens Ph.D
Leerink Transformation Partners

PatientPop stock FAQs

plusminus

Can you buy PatientPop stock?

You can no longer buy PatientPop stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

How to buy PatientPop stock?

You can no longer buy PatientPop stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.
plusminus

Can you sell PatientPop stock?

You can no longer sell stock of PatientPop on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

How to sell PatientPop stock?

You can no longer sell stock of PatientPop on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.
plusminus

Is PatientPop a public company?

PatientPop is now a public company.
plusminus

What is PatientPop’s stock price?

The stock price of PatientPop is not currently available.
plusminus

What is PatientPop’s stock ticker symbol?

The ticker symbol of PatientPop is not currently available.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: Dec 23, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge.  Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.